Display options
Share it on

medRxiv. 2020 Oct 20; doi: 10.1101/2020.10.17.20214510.

Association between live childhood vaccines and COVID-19 outcomes: a national-level analysis.

medRxiv : the preprint server for health sciences

Chikara Ogimi, Pingping Qu, Michael Boeckh, Rachel A Bender Ignacio, Sahar Z Zangeneh

Affiliations

  1. Pediatric Infectious Diseases Division, Seattle Children's Hospital, Seattle, WA, USA.
  2. Department of Pediatrics, University of Washington, Seattle, WA, USA.
  3. Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  4. Seattle Children's Research Institute, Seattle, WA, USA.
  5. Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  6. Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA, USA.

PMID: 33106815 PMCID: PMC7587835 DOI: 10.1101/2020.10.17.20214510

Abstract

We investigated whether countries with higher coverage of childhood live vaccines [BCG or measles-containing-vaccine (MCV)] have reduced risk of COVID-19 related mortality, accounting for known systems differences between countries. In this ecological study of 140 countries using publicly available national-level data, higher vaccine coverage, representing estimated proportion of people vaccinated during the last 15 years, was associated with lower COVID-19 deaths. The associations attenuated for both vaccine variables, and MCV coverage became no longer significant once adjusted for a validated summary score accounting for life expectancy and healthcare quality indicators, the Healthcare access and quality index (HAQI). The magnitude of association between BCG coverage and COVID-19 death rate varied according to HAQI, and MCV coverage had little effect on the association between BCG and COVID-19 deaths. While there are associations between live vaccine coverage and COVID-19 outcomes, the vaccine coverage variables themselves were strongly correlated with COVID-19 testing rate, HAQI, and life expectancy. This suggests that the population-level associations may be further confounded by differences in structural health systems and policies. Cluster randomized studies of booster vaccines would be ideal to evaluate the efficacy of trained immunity in preventing COVID-19 infections and mortality in vaccinated individuals and on community transmission.

References

  1. Arch Dis Child. 2017 Nov;102(11):1077-1081 - PubMed
  2. Cell Host Microbe. 2018 Jan 10;23(1):89-100.e5 - PubMed
  3. Euro Surveill. 2006;11(3):6-11 - PubMed
  4. Pediatr Infect Dis J. 2012 Mar;31(3):308-9 - PubMed
  5. JAMA. 2020 Jun 9;323(22):2340-2341 - PubMed
  6. Lancet. 2017 Jul 15;390(10091):231-266 - PubMed
  7. Acta Biomed. 2020 May 11;91(2):207-213 - PubMed
  8. Proc Natl Acad Sci U S A. 2020 Jul 28;117(30):17720-17726 - PubMed
  9. Immunity. 2020 May 19;52(5):737-741 - PubMed
  10. Nat Rev Immunol. 2020 Jun;20(6):335-337 - PubMed
  11. EMBO Mol Med. 2020 Jun 8;12(6):e12661 - PubMed
  12. Cell Death Dis. 2020 Jul 8;11(7):516 - PubMed
  13. PLoS Med. 2011 Mar;8(3):e1001012 - PubMed
  14. JAMA. 2020 Sep 16;: - PubMed
  15. J Clin Invest. 2020 Aug 3;130(8):3954-3956 - PubMed
  16. Clin Microbiol Infect. 2019 Dec;25(12):1473-1478 - PubMed
  17. Nature. 2020 Sep 30;: - PubMed
  18. Clin Epidemiol. 2017 Jun 08;9:331-338 - PubMed

Publication Types

Grant support